PL
JBIO

Parkwood LLC’s Jade Biosciences JBIO Stock Holding History

Parkwood LLC’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-528
Closed -$31K – 89
2024
Q2 		$31K Buy
528
+21
+4% +$13.9K ﹤0.01% 125
2024
Q1 		$524K Buy
507
+56
+12% +$42.8K 0.05% 164
2023
Q4 		$357K Sell
451
-139
-24% -$70.8K 0.04% 112
2023
Q3 		$280K Sell
590
-62
-10% -$33.6K 0.03% 116
2023
Q2 		$392K Sell
652
-87
-12% -$55.6K 0.07% 113
2023
Q1 		$522K Buy
739
+152
+26% +$126K 0.07% 113
2022
Q4 		$602K Sell
587
-23
-4% -$16.7K 0.09% 106
2022
Q3 		$354K Sell
610
-316
-34% -$211K 0.05% 126
2022
Q2 		$507K Buy
+926
New +$442K 0.09% 110
2022
Q1 		– Sell
-1,062
Closed -$438K – 132
2021
Q4 		$438K Sell
1,062
-311
-23% -$157K 0.07% 99
2021
Q3 		$1.01M Buy
+1,373
New +$769K 0.12% 94

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Parkwood LLC's JBIO Position: Q3 2024 in Review

Parkwood LLC sold out of Jade Biosciences (JBIO) in Q3 2024, closing a stake of 528 shares — an estimated $31K sold.

Parkwood LLC first reported a position in JBIO in Q3 2021 and held it in 11 quarters. The position peaked at $1.01M in Q3 2021. 72 funds tracked by Wall St. Rank hold JBIO as of Q3 2024.

  • Parkwood LLC reported no remaining Jade Biosciences position as of Q3 2024 after selling out during the quarter.
  • Parkwood LLC sold 528 Jade Biosciences shares in Q3 2024, an estimated $31K.
  • Parkwood LLC first reported a position in Jade Biosciences in Q3 2021 and held it in 11 quarters.
  • Parkwood LLC's Jade Biosciences position peaked at $1.01M in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2024.

Based on Parkwood LLC's 13F filing for Q3 2024, filed 14 Nov 2024.